9.86 +0.15 (1.54%)
Pre-Market: 7:41AM EDT
|Bid||9.85 x 2200|
|Ask||9.92 x 1000|
|Day's Range||9.61 - 11.30|
|52 Week Range||5.12 - 15.30|
|Beta (3Y Monthly)||3.49|
|PE Ratio (TTM)||971.00|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
While there didn’t seem to be massive, unexpected problems in the opening days of legal marijuana sales in Canada, it was difficult to determine whether the still fragile distribution network has been able to keep pace with demand.
Cannabis will be legal in Canada starting this Wednesday, generating strong interest from investors eager to get in on a market that analysts and experts expect to be worth billions of dollars.
Don’t get swept up in all the hoopla over Canadian legalization, where a limited market and falling prices may produce big losses.
Heinz may design the genetic makeup of the tomatoes used for its renowned ketchup, but it doesn’t own the farms that grow the fruit. Toronto-based weed company Cronos Group is aiming to duplicate that model.
NEW YORK, Oct. 19, 2018 -- Pomerantz LLP announces that a class action lawsuit has been filed against Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) and certain.
This was widely seen as the biggest catalyst for pot stocks in recent memory. Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY), Cronos (NASDAQ:CRON) and Aurora (OTCMKTS:ACBFF) have all dropped from their pre-legalization highs. Once this pause is over, it will be time to buy the best pot stocks.
TORONTO , Oct. 19, 2018 /CNW/ - Cronos Group Inc. (CRON) (CRON.TO) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, will announce its financial results and hold its Third Quarter 2018 Earnings Conference Call on Tuesday, November 13, 2018 at 8:30 a.m. EDT . A live audio webcast of the earnings call will be available on the Company's website at https://thecronosgroup.com/investor-relations. The call will be archived on the Company's website for replay.
TORONTO, Oct. 19, 2018 /PRNewswire/ - Cronos Group Inc. (CRON) (CRON.TO) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, will announce its financial results and hold its Third Quarter 2018 Earnings Conference Call on Tuesday, November 13, 2018 at 8:30 a.m. EDT. A live audio webcast of the earnings call will be available on the Company's website at https://thecronosgroup.com/investor-relations. The call will be archived on the Company's website for replay.
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cronos Group Inc. (“Cronos” or the “Company”) (CRON) of the November 5, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
HENDERSON, NV / ACCESSWIRE / October 18, 2018 / October is Liver Cancer Awareness month. According to the American Cancer Society, liver cancer incidence has more than tripled since 1980, liver cancer death rates have increased by almost 3% per year since 2000 and more than 700,000 people are diagnosed with liver cancer each year throughout the world. Liver cancer is also a leading cause of cancer deaths worldwide, accounting for more than 600,000 deaths each year.
HENDERSON, NV / ACCESSWIRE / October 18, 2018 / Below are a few Medical stocks that are in position to make their investors major profit in the coming sessions.The company on our radar today, however, ...
Weed is finally legal in Canada. That is big news for pot stocks. Names like Cronos (NASDAQ:CRON), Tilray (NASDAQ:TLRY) and Canopy Growth (NYSE:CGC) all rallied big into this event as it was widely perceived as the biggest legal breakthrough yet in the still nascent cannabis narrative. Yet, the legalization of weed in Canada has become a “sell the news” event for pot stocks. On Oct. 17 — the day weed became legal — pot stocks dropped. As of writing, CRON stock is down 7% from Tuesday’s adjusted close. TLRY stock is down 6%, too, while CGC stock is down 4%.
Law Offices of Howard G. Smith reminds investors of the November 5, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Cronos Group, Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) securities between August 21, 2018, and August 30, 2018, inclusive (the “Class Period”). Cronos investors have until November 5, 2018 to file a lead plaintiff motion. Investors suffering losses on their Cronos investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to email@example.com.
NEW YORK, NY / ACCESSWIRE / October 17, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Cronos Group Inc. (NASDAQ: CRON) from ...
Trading of cannabis stocks has been a part of life for years on Canada’s major exchange, but Wednesday’s official kickoff of recreational cannabis sales in the country was still a cause for a celebration.
NEW YORK, NY / ACCESSWIRE / October 17, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Cronos Group Inc. (''Cronos'' or the ''Company'') (CRON) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and index under 18-cv-08406, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Cronos securities between August 21, 2018 and August 30, 2018, both dates inclusive (the ''Class Period''), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
This is a landmark week for investors in one of 2018’s most active market segments, as Canada has officially opened its doors to become the world's largest federally legal cannabis market. Cannabis has always been a volatile sector, dating back to when the first cannabis stocks began trading several years ago. Growth in the cannabis market has happened in both the exchange and the over-the-counter space.
TORONTO , Oct. 17, 2018 /PRNewswire/ - Today, Canada became the first G7 country and the second country in the world to legalize cannabis sales for adult recreational use. Founded to build industry leading ...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cronos Group, Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Cronos securities between August 21, 2018, and August 30, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/cron. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
Shares of companies in the cannabis business were broadly, and in many cases sharply lower, despite marijuana becoming fully legal in Canada. The ETFMG Alternative Harvest ETF tumbled 6.5% in morning trade, with 27 of 37 components trading lower, to extend Tuesday's 3.7% pullback. Among the more active pot stocks, Canopy Growth Corp. dropped 8.2%, Tilray Inc. lost 6.0%, Aurora Cannabis Inc. plunged 15%, Cronos Group Inc. slumped 9.9%, New Age Beverages Corp. shed 9.0%, India Globalization Capital Inc. slid 7.3% and MedMen Enterprises Inc. lost 6.0%. As of Wednesday, Canada became only the second country in the world to legalize marijuana for recreational use. The pot sector ETF has now gained 39% over the past three months, while the S&P 500 has slipped 0.2%. More about the emerging cannabis sector: A guide to pot stocks: What you need to know to invest in cannabis companies
After historic legislation that moved Canada as the first G7 member state to legalize recreational marijuana, it became official. This has significant implications, especially for marijuana stocks. As such, investors should strongly consider marijuana stocks to buy, irrespective of their personal reservations.
Some investors might be thinking “what are bulls smoking” in Canopy Growth Corp (NYSE:CGC). An out-the-gate bid in CGC stock on Tuesday immediately in front of Canada’s anxiously awaited legalization of recreational marijuana Wednesday turned quickly into a case of the jitters. One could blame wild price action on an anticipatory ‘sell-the-news’ reaction by an increasingly fast market.
Yahoo Finance’s Seana Smith on the stocks making headlines in midday trading Wednesday.
Recreational marijuana is now legal in Canada. What does that mean for investors here in the U.S.? Yahoo Finance's Seana Smith, Adam Shapiro, Andy Serwer and Alexis Keenan weigh in and discuss the long-term opportunities for investment with Marijuana Business Daily's Founder Editor Chris Walsh.